羟基脲联合干扰素治疗糖尿病合并真性红细胞增多症疗效观察(1)
[摘要] 目的 探討羟基脲联合干扰素治疗糖尿病合并真性红细胞增多症的效果。 方法 选取该科2016年6月—2018年6月收治的42例糖尿病合并PV患者,随机分为两组,各21例,观察组采用羟基脲联合干扰素治疗,对照组采用羟基脲治疗。结果 观察组总有效率为90.5%,显著高于对照组76.2%(P<0.05);两组FPG比较差异无统计学意义(P>0.05),观察组Hb、RBC、PLT、HCT较对照组显著下降(P<0.05)。 结论 羟基脲联合干扰素治疗糖尿病合并PV能有效抑制骨髓成纤维细胞的增殖,改善症状和预后。[关键词] 羟基脲;干扰素;糖尿病;真性红细胞增多症
[中图分类号] R587.1 [文献标识码] A [文章编号] 1672-4062(2019)04(a)-0073-02
[Abstract] Objective To investigate the effect of hydroxyurea combined with interferon in the treatment of diabetes complicated with polycythemia. Methods Forty-two patients with diabetes mellitus complicated with PV admitted to our department from June 2016 to June 2018 were randomly divided into two groups: 21 patients each. The observation group was treated with hydroxyurea combined with interferon ......
您现在查看是摘要页,全文长 3205 字符。